Order Article Reprints

Kim P, Nadarajan V, Ahmed M, Furman K, Gurm Z, Kale P, Khoury Z, Koussa S, LaBuda D, Mekjian M, et al. The Associations of Antihypertensive Medications, Steroids, Beta Blockers, Statins and Comorbidities with COVID-19 Outcomes in Patients with and without Chronic Kidney Disease: A Retrospective Study. COVID. 2023; 3(5):682-692. https://doi.org/10.3390/covid3050050

Kim, Paul, Vidhya Nadarajan, Maham Ahmed, Katerina Furman, Zoya Gurm, Priyanka Kale, Zaina Khoury, Sara Koussa, Dana LaBuda, Margo Mekjian, and et al. 2023. "The Associations of Antihypertensive Medications, Steroids, Beta Blockers, Statins and Comorbidities with COVID-19 Outcomes in Patients with and without Chronic Kidney Disease: A Retrospective Study" COVID 3, no. 5: 682-692. https://doi.org/10.3390/covid3050050

Kim, P., Nadarajan, V., Ahmed, M., Furman, K., Gurm, Z., Kale, P., Khoury, Z., Koussa, S., LaBuda, D., Mekjian, M., Polamarasetti, P., Simo, L., Thill, C., Wittenberg, S., Dhar, S., & Komnenov, D. (2023). The Associations of Antihypertensive Medications, Steroids, Beta Blockers, Statins and Comorbidities with COVID-19 Outcomes in Patients with and without Chronic Kidney Disease: A Retrospective Study. COVID, 3(5), 682-692. https://doi.org/10.3390/covid3050050